Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Current Deferred Revenue: 2012-2018

Historic Current Deferred Revenue for Catalyst Pharmaceuticals (CPRX) over the last 5 years, with Dec 2018 value amounting to $33,408.

  • Catalyst Pharmaceuticals' Current Deferred Revenue rose 39.14% to $33,408 in Q4 2018 from the same period last year, while for Dec 2018 it was $33,408, marking a year-over-year increase of 39.14%. This contributed to the annual value of $33,408 for FY2018, which is 39.14% up from last year.
  • Catalyst Pharmaceuticals' Current Deferred Revenue amounted to $33,408 in Q4 2018, which was up 52.45% from $21,914 recorded in Q3 2018.
  • In the past 5 years, Catalyst Pharmaceuticals' Current Deferred Revenue registered a high of $33,408 during Q4 2018, and its lowest value of $3,254 during Q1 2014.
  • For the 3-year period, Catalyst Pharmaceuticals' Current Deferred Revenue averaged around $23,647, with its median value being $22,424 (2017).
  • In the last 5 years, Catalyst Pharmaceuticals' Current Deferred Revenue skyrocketed by 335.14% in 2015 and then decreased by 2.27% in 2018.
  • Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' Current Deferred Revenue stood at $4,158 in 2014, then skyrocketed by 335.14% to $18,093 in 2015, then grew by 0.01% to $18,094 in 2016, then soared by 32.70% to $24,011 in 2017, then soared by 39.14% to $33,408 in 2018.
  • Its last three reported values are $33,408 in Q4 2018, $21,914 for Q3 2018, and $27,184 during Q2 2018.